207 related articles for article (PubMed ID: 3315236)
1. Polymeric prodrugs.
Azori M
Crit Rev Ther Drug Carrier Syst; 1987; 4(1):39-65. PubMed ID: 3315236
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
3. Polymeric prodrugs.
Hoste K; De Winne K; Schacht E
Int J Pharm; 2004 Jun; 277(1-2):119-31. PubMed ID: 15158975
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in prodrugs as drug delivery systems.
Lin C; Sunkara G; Cannon JB; Ranade V
Am J Ther; 2012 Jan; 19(1):33-43. PubMed ID: 21150770
[TBL] [Abstract][Full Text] [Related]
6. Prodrugs: design and clinical applications.
Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of dendrimers and drug-dendrimer conjugates for drug delivery.
Najlah M; D'Emanuele A
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):756-67. PubMed ID: 17987527
[TBL] [Abstract][Full Text] [Related]
8. Polymeric anticancer drugs with pH-controlled activation.
Ulbrich K; Subr V
Adv Drug Deliv Rev; 2004 Apr; 56(7):1023-50. PubMed ID: 15066758
[TBL] [Abstract][Full Text] [Related]
9. Chemical modification and formulation approaches to elevated drug transport across cell membranes.
Majumdar S; Mitra AK
Expert Opin Drug Deliv; 2006 Jul; 3(4):511-27. PubMed ID: 16822226
[TBL] [Abstract][Full Text] [Related]
10. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutically used polymers: principles, structures, and applications of pharmaceutical delivery systems.
Khandare J; Haag R
Handb Exp Pharmacol; 2010; (197):221-50. PubMed ID: 20217532
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
Reza MS; Quadir MA; Haider SS
J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
[TBL] [Abstract][Full Text] [Related]
13. Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms.
Siepmann J; Siepmann F; Florence AT
Int J Pharm; 2006 May; 314(2):101-19. PubMed ID: 16647231
[TBL] [Abstract][Full Text] [Related]
14. Prodrug strategies in anticancer chemotherapy.
Kratz F; Müller IA; Ryppa C; Warnecke A
ChemMedChem; 2008 Jan; 3(1):20-53. PubMed ID: 17963208
[TBL] [Abstract][Full Text] [Related]
15. Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics.
Gaspar R; Duncan R
Adv Drug Deliv Rev; 2009 Nov; 61(13):1220-31. PubMed ID: 19682513
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting toxicity and efficacy of polymeric nanomedicines.
Igarashi E
Toxicol Appl Pharmacol; 2008 May; 229(1):121-34. PubMed ID: 18355886
[TBL] [Abstract][Full Text] [Related]
17. Polymeric nanoparticles for the drug delivery to the central nervous system.
Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
[TBL] [Abstract][Full Text] [Related]
18. Drug targeting using conjugates: the importance of pharmaceutical chemistry.
Byrn SR; Stowell JG
J Drug Target; 1995; 3(4):239-41. PubMed ID: 8820996
[No Abstract] [Full Text] [Related]
19. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.
Al-Kassas RS; El-Khatib MM
Drug Deliv; 2009 Apr; 16(3):145-52. PubMed ID: 19514974
[TBL] [Abstract][Full Text] [Related]
20. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]